Home / About Novasep / Media & Events / Press releases

Press releases

Novasep and Celladon Execute MYDICAR API supply agreement

24 Mar 2015

Pompey, France, and San Diego, CA, USA, March 24, 2015 - Novasep, a leading supplier of services and technologies for the life sciences and chemical industries and Celladon Corporation (Nasdaq:CLDN), a clinical-stage cardiovascular gene therapy company, today announce that they have signed a Development, Manufacturing and Supply Agreement pursuant to which, if supported by upcoming MYDICAR clinical data, Novasep would manufacture MYDICAR drug substance through 2018 with extension options through 2020.


Novasep selected to commercially biomanufacture Celladon’s Mydicar API

17 Feb 2015

Novasep, a leading supplier of services and technologies for the life sciences industry, today announces that it has entered into an agreement with Celladon, a clinical-stage biotechnology company. Novasep will prepare to supply the drug substance for MYDICAR®.


Novasep opens new office in Thailand

15 Dec 2014

Novasep’s extended presence in South East Asia strengthens the company’s ability to address growing needs in the region’s food and feed markets.


Novasep and partner Nilsan Nishotech to install the first continuous chromatography system at Laurus Labs

13 Nov 2014

Novasep Varicol high-performance continuous chromatography technology brings productivity gains in an Indian-based API commercial production.


Novasep to sell its Bahamian plant to local investor

02 Oct 2014

Pompey, October 2, 2014: Novasep, a leading supplier of manufacturing solutions to the life sciences industry, announces that it has completed the sale of the Bahamian facility and related business of its fully-owned subsidiary, Pharmachem Technologies (Grand Bahama) Ltd (Pharmachem), to a local investor.


Novasep passes FDA inspections on two sites

22 Jul 2014

Novasep wins approval to produce new molecular entity for US market.


Novasep-MIE consortium to construct the first sorbitol production plant in Vietnam

17 Jun 2014

The plant will enable Vietnam to domestically produce sorbitol, a sugar substitute it currently imports.


Novasep’s EUR 4 million plant extension for commercial ADC payload manufacturing now commissioned

15 May 2014

The new Highly Potent API (HPAPI) manufacturing capacity at the Le Mans facility will boost Novasep’s ability to meet customer demand for producing anti-cancer therapies.


Novasep reports full year 2013 results showing strong growth and beating guidance

27 Mar 2014

France, March 27th, 2014 - Novasep, a leading supplier of manufacturing solutions to Life Science industries, today announces its unaudited consolidated results1 for the period ended December 31st, 2013.


Novasep appoints CEO Michel Spagnol as Chairman of the Supervisory Board, Novasep presents strategic developments

04 Mar 2014

Pompey, France, March 4, 2014 - Novasep, a leading provider of global manufacturing solutions for life science molecules and fine chemicals, today announces the appointment of Michel Spagnol as chairman of the Supervisory Board, following the departure of Roger-Marc Nicoud, the founder of the group. Novasep provides an update of its strategic projects.



You can stay on this page and select more documents or you can directly download the brochure(s) you selected
Give us your feedback!